﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Cardiovascular and Thoracic Research</JournalTitle>
      <Issn>2008-5117</Issn>
      <Volume>12</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2020</Year>
        <Month>12</Month>
        <DAY>16</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Association of rs4618210A&gt;G variant in PLCL2 gene with myocardial infarction: A case-control study in Iran</ArticleTitle>
    <FirstPage>303</FirstPage>
    <LastPage>306</LastPage>
    <ELocationID EIdType="doi">10.34172/jcvtr.2020.49</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Najmeh</FirstName>
        <LastName>Ramezanpour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0820-4983</Identifier>
      </Author>
      <Author>
        <FirstName>Mahboobeh</FirstName>
        <LastName>Nasiri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1370-6849</Identifier>
      </Author>
      <Author>
        <FirstName>Omid Reza</FirstName>
        <LastName>Akbarpour</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jcvtr.2020.49</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>06</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>10</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Myocardial infarction (MI) is the leading cause of death all over the world. The pivotal roles of Phospholipase C like 2 gene (PLCL2) in calcium homeostasis and immune responses make this gene as a potential candidate for its role in MI pathogenesis. The present study was undertaken to investigate whether rs4618210A&gt;G polymorphism in PLCL2 gene contribute to MI etiology. Methods: A hospital-based case-control study with 600 subjects, including 300 MI patients and 300controls, was conducted. Genotyping of PLCL2 rs4618210 polymorphism was performed using amplification refractory mutation system-polymerase chain reaction (ARMS PCR) method. Data were analyzed using logistic regression analysis. Results: No significant association was found between the PLCL2 rs4618210 alleles and MI risk.However, a significantly increased risk of MI was observed among carriers of the AG genotype (OR= 1.91; 95% CI = 1.24 - 2.93; P = 0.003) compared with AA homozygote. In a dominant mode of inheritance for G allele (GG + AG vs. AA), the frequency of the carriers of at least one G allele was higher in cases compared to controls (OR= 1.56; 95% CI: 1.03 – 2.36; P = 0.037). Conclusion: Our study provided further evidence that PLCL2 gene polymorphism may serve as a prognostic marker for MI.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Polymorphism</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">PLCL2</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Myocardial Infraction</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>